Skip to main content
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.28
-0.36 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
10.27
-0.01 (-0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT

Vir Biotechnology Revenue

In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%. Vir Biotechnology had revenue of $64.07M in the quarter ending December 31, 2025, with 417.78% growth.

Revenue (ttm)
$68.56M
Revenue Growth
-7.61%
P/S Ratio
24.18
Revenue / Employee
$186,801
Employees
367
Market Cap
1.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Innoviva 411.33M
AnaptysBio 234.60M
Monte Rosa Therapeutics 123.67M
Nurix Therapeutics 71.78M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Nanobiotix 38.27M
Generate Biomedicines 31.89M
Revenue Rankings

VIR News

More News